Cargando…

Development and Validation of a Prognostic Nomogram for Colorectal Cancer Patients With Synchronous Peritoneal Metastasis

PURPOSE: Synchronous peritoneal metastasis (S-PM) is considered a poor prognostic factor for colorectal cancer (CRC) and there is no nomogram to predict the survival of these patients. In this study, we aimed to use a multicenter data to identify the factors associated with S-PM of CRC to construct...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Zifeng, Li, Yong, Qin, Xiusen, Lv, Zejian, Wang, Huaiming, Wu, Deqing, Yuan, Zixu, Wang, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8281961/
https://www.ncbi.nlm.nih.gov/pubmed/34277396
http://dx.doi.org/10.3389/fonc.2021.615321
_version_ 1783722918098763776
author Yang, Zifeng
Li, Yong
Qin, Xiusen
Lv, Zejian
Wang, Huaiming
Wu, Deqing
Yuan, Zixu
Wang, Hui
author_facet Yang, Zifeng
Li, Yong
Qin, Xiusen
Lv, Zejian
Wang, Huaiming
Wu, Deqing
Yuan, Zixu
Wang, Hui
author_sort Yang, Zifeng
collection PubMed
description PURPOSE: Synchronous peritoneal metastasis (S-PM) is considered a poor prognostic factor for colorectal cancer (CRC) and there is no nomogram to predict the survival of these patients. In this study, we aimed to use a multicenter data to identify the factors associated with S-PM of CRC to construct a nomogram for predicting the overall survival (OS) of these patients. METHODS: CRC patients with S-PM from two medical centers were enrolled between September 2007 and June 2017. Multivariate analysis was used to identify independent factors associated with OS for the nomogram to predict the 1-, 2-, and 3-year OS rates in the development group. The concordance index (C-index), calibration plot, relative operating characteristic (ROC) curve with area under the curve (AUC) were calculated to evaluate the performance of the nomogram in both the development and an external validation group. RESULTS: 277 CRC patients with S-PM in the development group and 68 patients in the validation group were eligible for this study. In multivariate analysis of development group, age, carbohydrate antigen 19-9 (CA19-9), carbohydrate antigen 125 (CA125), cytoreductive surgery (CRS), hyperthermic intraperitoneal chemotherapy (HIPEC), and chemotherapy were independent variables for OS, based on which the nomogram was built. The C-index of the nomogram in the development and validation group was 0.701 (95% Cl, 0.666–0.736) and 0.716 (95% Cl, 0.622–0.810); demonstrating good discriminative ability. The calibration plots showed satisfactory consistency between actual observation and nomogram-predicted OS probabilities in the development and external validation group. The nomogram showed good predictive accuracy for 1-, 2-, and 3-year OS rates in both groups with AUC >0.70. An online dynamic webserver was also developed for increasing the ease of the nomogram. CONCLUSIONS: We developed and validated a predictive nomogram with good discriminative and high accuracy to predict the OS in CRC patients with S-PM.
format Online
Article
Text
id pubmed-8281961
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-82819612021-07-16 Development and Validation of a Prognostic Nomogram for Colorectal Cancer Patients With Synchronous Peritoneal Metastasis Yang, Zifeng Li, Yong Qin, Xiusen Lv, Zejian Wang, Huaiming Wu, Deqing Yuan, Zixu Wang, Hui Front Oncol Oncology PURPOSE: Synchronous peritoneal metastasis (S-PM) is considered a poor prognostic factor for colorectal cancer (CRC) and there is no nomogram to predict the survival of these patients. In this study, we aimed to use a multicenter data to identify the factors associated with S-PM of CRC to construct a nomogram for predicting the overall survival (OS) of these patients. METHODS: CRC patients with S-PM from two medical centers were enrolled between September 2007 and June 2017. Multivariate analysis was used to identify independent factors associated with OS for the nomogram to predict the 1-, 2-, and 3-year OS rates in the development group. The concordance index (C-index), calibration plot, relative operating characteristic (ROC) curve with area under the curve (AUC) were calculated to evaluate the performance of the nomogram in both the development and an external validation group. RESULTS: 277 CRC patients with S-PM in the development group and 68 patients in the validation group were eligible for this study. In multivariate analysis of development group, age, carbohydrate antigen 19-9 (CA19-9), carbohydrate antigen 125 (CA125), cytoreductive surgery (CRS), hyperthermic intraperitoneal chemotherapy (HIPEC), and chemotherapy were independent variables for OS, based on which the nomogram was built. The C-index of the nomogram in the development and validation group was 0.701 (95% Cl, 0.666–0.736) and 0.716 (95% Cl, 0.622–0.810); demonstrating good discriminative ability. The calibration plots showed satisfactory consistency between actual observation and nomogram-predicted OS probabilities in the development and external validation group. The nomogram showed good predictive accuracy for 1-, 2-, and 3-year OS rates in both groups with AUC >0.70. An online dynamic webserver was also developed for increasing the ease of the nomogram. CONCLUSIONS: We developed and validated a predictive nomogram with good discriminative and high accuracy to predict the OS in CRC patients with S-PM. Frontiers Media S.A. 2021-07-01 /pmc/articles/PMC8281961/ /pubmed/34277396 http://dx.doi.org/10.3389/fonc.2021.615321 Text en Copyright © 2021 Yang, Li, Qin, Lv, Wang, Wu, Yuan and Wang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Yang, Zifeng
Li, Yong
Qin, Xiusen
Lv, Zejian
Wang, Huaiming
Wu, Deqing
Yuan, Zixu
Wang, Hui
Development and Validation of a Prognostic Nomogram for Colorectal Cancer Patients With Synchronous Peritoneal Metastasis
title Development and Validation of a Prognostic Nomogram for Colorectal Cancer Patients With Synchronous Peritoneal Metastasis
title_full Development and Validation of a Prognostic Nomogram for Colorectal Cancer Patients With Synchronous Peritoneal Metastasis
title_fullStr Development and Validation of a Prognostic Nomogram for Colorectal Cancer Patients With Synchronous Peritoneal Metastasis
title_full_unstemmed Development and Validation of a Prognostic Nomogram for Colorectal Cancer Patients With Synchronous Peritoneal Metastasis
title_short Development and Validation of a Prognostic Nomogram for Colorectal Cancer Patients With Synchronous Peritoneal Metastasis
title_sort development and validation of a prognostic nomogram for colorectal cancer patients with synchronous peritoneal metastasis
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8281961/
https://www.ncbi.nlm.nih.gov/pubmed/34277396
http://dx.doi.org/10.3389/fonc.2021.615321
work_keys_str_mv AT yangzifeng developmentandvalidationofaprognosticnomogramforcolorectalcancerpatientswithsynchronousperitonealmetastasis
AT liyong developmentandvalidationofaprognosticnomogramforcolorectalcancerpatientswithsynchronousperitonealmetastasis
AT qinxiusen developmentandvalidationofaprognosticnomogramforcolorectalcancerpatientswithsynchronousperitonealmetastasis
AT lvzejian developmentandvalidationofaprognosticnomogramforcolorectalcancerpatientswithsynchronousperitonealmetastasis
AT wanghuaiming developmentandvalidationofaprognosticnomogramforcolorectalcancerpatientswithsynchronousperitonealmetastasis
AT wudeqing developmentandvalidationofaprognosticnomogramforcolorectalcancerpatientswithsynchronousperitonealmetastasis
AT yuanzixu developmentandvalidationofaprognosticnomogramforcolorectalcancerpatientswithsynchronousperitonealmetastasis
AT wanghui developmentandvalidationofaprognosticnomogramforcolorectalcancerpatientswithsynchronousperitonealmetastasis